Overview

Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis

Status:
Not yet recruiting
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
To explore the feasibility of combined topical corticosteroid and topical cyclosporine-A in COVID-19 patients with acute keratoconjunctivitis.
Phase:
N/A
Details
Lead Sponsor:
Ameera Gamal Abdelhameed
Collaborator:
Ministry of Health, Kuwait
Treatments:
Cyclosporine
Cyclosporins